Pills [bodm]
Polypharmacy [fndg]
Prevail [phsu]
Patients [podg]
Anticoagulant [phsu]
Clinic [hcro, mnob]
Purpose [ftcn]
vitamin k antagonist [topp]
treatment [ftcn]
PREVENT [phsu]
thromboembolic [ftcn]
Complications [patf]
Modality [idcn]
Narrow [qlco]
Therapeutic [topp]
Window [mnob]
Numerous [qnco]
Interaction [ftcn]
Pharmaceuticals [topp]
Aim [idcn]
Study [mnob]
Reported [inpr]
To [qlco]
Medications [phsu]
Prevalence [qnco]
Polypharmacy [fndg]
Patients [podg]
treated [topp]
vitamin k antagonist [topp]
Methods [inpr]
Cross-Sectional Study [resa]
Consecutive [qlco]
Patients [podg]
Male [fndg]
median [spco]
Age-Years [tmco]
Common [qnco]
indication [idcn]
vitamin k antagonist [topp]
treatment [ftcn]
Atrial Fibrillation [patf]
Maintenance [acty]
Phase [tmco]
vitamin k antagonist [topp]
treatment [ftcn]
Interview [acty]
Prescription [hlca]
Medications [phsu]
Over-the-Counter Drugs [phsu]
alternative medicines [bmod]
Last [qlco]
days [tmco]
Result [ftcn]
interview patient [hlca]
median [spco]
Five [qnco]
Medications [phsu]
Range [qnco]
Including [ftcn]
vitamin k antagonist [topp]
Approximately [qlco]
Patients [podg]
Take [hlca]
alternative medicines [bmod]
Wide [spco]
Range [qnco]
Conventional [qlco]
alternative medicines [bmod]
Several [qnco]
Harbor [mnob]
Possible [qlco]
Interaction [ftcn]
vitamin k antagonist [topp]
Polypharmacy [fndg]
Defined [cnce]
Five [qnco]
More [ftcn]
Medications [phsu]
Exclude [ftcn]
alternative medicines [bmod]
Group [idcn]
Polypharmacy [fndg]
Patients [podg]
included [ftcn]
Study Population [popg]
Amiodarone [orch, phsu]
Age [orga]
indication [idcn]
vitamin k antagonist [topp]
treatment [ftcn]
Atrial Fibrillation [patf]
HEART-VALVE, MECHANICAL [medd]
Diabetes [dsyn]
Independent [idcn]
Predictor [idcn]
Polypharmacy [fndg]
Conclusions [idcn]
Result [ftcn]
Study [mnob]
Polypharmacy [fndg]
Common [qnco]
Phenomenon [phpr]
Patients [podg]
Anticoagulant [phsu]
Medication [phsu]
Elderly [popg]
Patients [podg]
Suffering [mobd]
Cardiovascular disease [dsyn]
Diabetes [dsyn]
